Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation
1 other identifier
interventional
50
1 country
1
Brief Summary
The investigators will examine the balance between IVF success in terms of outcome parameters, using a mild ovarian stimulation protocol, opposing it to the conventional stimulation regimens in poor responders undergoing IVF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Mar 2011
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 8, 2011
CompletedFirst Posted
Study publicly available on registry
March 22, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedNovember 10, 2015
November 1, 2015
4.5 years
March 8, 2011
November 7, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of oocytes (COCs)
at oocyte recovery
Secondary Outcomes (6)
Number/rate of participants whom the IVF cycle was cancelled
After the 1st week of ovarian stimulation, no oocytes at OR
clinical pregnancy rate
6 weeks
live birth
more than 20 weeks
miscarriage
pregnancy loss before 20 weeks of gestation, after a positive pregnancy test
stimulation characteristics
from start of stimulation until embryo transfer
- +1 more secondary outcomes
Study Arms (2)
mild ovarian stimulation
EXPERIMENTAL100 mg CC by day 2 till 6, plus antagonist plus gonadotrophin 150-200IO until HCG triggering
conventional ovarian stimulation
ACTIVE COMPARATOR300-450 IU of FSH starting by day 2 of menstrual cycle together with a fixed dose of GnRH antagonist starting by day 6 till egg recovery, or same doses using a GnRH agonist long protocol
Interventions
100-150 mg of clomiphene citrate from day 2 till day 6 of the cycle and 150 mg of gonadotrophins as soon as 1 follicle is more than 14mm together with 1 fixed dose of GnRH antagonist until egg recovery
300-450 IU of FSH starting by day 2 of menstrual cycle together with a fixed dose of GnRH antagonist starting by day 6 till egg recovery, or same doses with GnRH agonist long protocol
Eligibility Criteria
You may qualify if:
- poor responders (age\>40, previous POR, abnormal OR test)
- indication for IVF
- regular cycling patients
- BMI 19-35
You may not qualify if:
- contraindication for clomiphene citrate use or to GnRH agonists antagonists
- BMI \> 35
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
3rd Department of Obstetrics & Gynecology, Assisted Reproduction Unit
Athens, Chaidari, 12462, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Director of the ARU
Study Record Dates
First Submitted
March 8, 2011
First Posted
March 22, 2011
Study Start
March 1, 2011
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
November 10, 2015
Record last verified: 2015-11